Boucher Kelley has filed 19 insider transactions across 1 company since May 2025.
Most recent transaction: a disposition of 45766 shares of Apellis Pharmaceuticals, Inc. ($APLS) on May 14, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 14, 2026 | Apellis Pharmaceuticals, Inc. | $APLS | Boucher Kelley | Chief People Officer | D | Stock Option (right to buy) | 45766 | $0.00 | 0.0000 | 130,067,000 | 100.00% | 0.04% |
| May 14, 2026 | Apellis Pharmaceuticals, Inc. | $APLS | Boucher Kelley | Chief People Officer | D | Common Stock | 30146 | $0.00 | 0.0000 | 130,067,000 | 100.00% | 0.02% |
| May 14, 2026 | Apellis Pharmaceuticals, Inc. | $APLS | Boucher Kelley | Chief People Officer | D | Common Stock | 22087 | $0.00 | 0.0000 | 130,067,000 | 100.00% | 0.02% |
| May 14, 2026 | Apellis Pharmaceuticals, Inc. | $APLS | Boucher Kelley | Chief People Officer | D | Common Stock | 45095 | $0.00 | 0.0000 | 130,067,000 | 100.00% | 0.03% |
| May 14, 2026 | Apellis Pharmaceuticals, Inc. | $APLS | Boucher Kelley | Chief People Officer | D | Common Stock | 30476 | $0.00 | 0.0000 | 130,067,000 | 100.00% | 0.02% |
| May 14, 2026 | Apellis Pharmaceuticals, Inc. | $APLS | Boucher Kelley | Chief People Officer | D | Common Stock | 30146 | $0.00 | 0.0000 | 130,067,000 | 100.00% | 0.02% |
| May 14, 2026 | Apellis Pharmaceuticals, Inc. | $APLS | Boucher Kelley | Chief People Officer | D | Stock Option (right to buy) | 32976 | $0.00 | 0.0000 | 130,067,000 | 100.00% | 0.03% |
| May 14, 2026 | Apellis Pharmaceuticals, Inc. | $APLS | Boucher Kelley | Chief People Officer | D | Stock Option (right to buy) | 67396 | $0.00 | 0.0000 | 130,067,000 | 100.00% | 0.05% |
| May 14, 2026 | Apellis Pharmaceuticals, Inc. | $APLS | Boucher Kelley | Chief People Officer | U | Common Stock | 127804 | $0.00 | 0.0000 | 130,067,000 | 100.00% | 0.10% |
| May 14, 2026 | Apellis Pharmaceuticals, Inc. | $APLS | Boucher Kelley | Chief People Officer | A | Common Stock | 15073 | $0.00 | 15,073.0000 | 130,067,000 | 9999.99% | 0.01% |
| May 14, 2026 | Apellis Pharmaceuticals, Inc. | $APLS | Boucher Kelley | Chief People Officer | D | Common Stock | 15073 | $0.00 | 0.0000 | 130,067,000 | 100.00% | 0.01% |
| May 14, 2026 | Apellis Pharmaceuticals, Inc. | $APLS | Boucher Kelley | Chief People Officer | A | Common Stock | 30146 | $0.00 | 30,146.0000 | 130,067,000 | 9999.99% | 0.02% |
| Jan. 28, 2026 | Apellis Pharmaceuticals, Inc. | $APLS | Boucher Kelley | Chief People Officer | A | Common Stock | 30146 | $0.00 | 127,804.0000 | 130,067,000 | 30.87% | 0.02% |
| Sept. 2, 2025 | Apellis Pharmaceuticals, Inc. | $APLS | Boucher Kelley | Chief People Officer | A | Common Stock | 30476 | $0.00 | 97,658.0000 | 123,905,000 | 45.36% | 0.02% |
| Sept. 2, 2025 | Apellis Pharmaceuticals, Inc. | $APLS | Boucher Kelley | Chief People Officer | A | Stock Option (Right to Buy) | 45766 | $0.00 | 45,766.0000 | 123,905,000 | 9999.99% | 0.04% |
| June 9, 2025 | Apellis Pharmaceuticals, Inc. | $APLS | Boucher Kelley | Chief People Officer | A | Stock Option (Right to Buy) | 67396 | $19.39 | 67,396.0000 | 123,905,000 | 9999.99% | 0.05% |
| June 9, 2025 | Apellis Pharmaceuticals, Inc. | $APLS | Boucher Kelley | Chief People Officer | A | Common Stock | 45095 | $0.00 | 67,182.0000 | 123,905,000 | 204.17% | 0.04% |
| May 28, 2025 | Apellis Pharmaceuticals, Inc. | $APLS | Boucher Kelley | Chief People Officer | A | Common Stock | 22087 | $0.00 | 22,087.0000 | 123,905,000 | 9999.99% | 0.02% |
| May 28, 2025 | Apellis Pharmaceuticals, Inc. | $APLS | Boucher Kelley | Chief People Officer | A | Stock Option (Right to Buy) | 32976 | $16.80 | 32,976.0000 | 123,905,000 | 9999.99% | 0.03% |